about
Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model.PERK: a novel therapeutic target for neurodegenerative diseases?Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexAnti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's diseaseAssociations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-AnalysisAlzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules.A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides.Basic science breaks through: New therapeutic advances in Parkinson's disease.Ultrasound treatment of neurological diseases--current and emerging applications.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.Anti-Aβ single-chain variable fragment antibodies restore memory acquisition in a Drosophila model of Alzheimer's diseaseDecreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models.Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to Aβ immunotherapy.Tau-based therapies in neurodegeneration: opportunities and challenges.Widespread brain distribution and activity following i.c.v. infusion of anti-β-secretase (BACE1) in nonhuman primates.Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
P2860
Q33603862-D6B00911-175E-496D-A3C8-756CD4A3B07CQ33821900-21A101FD-D774-4B2F-90B3-E87E938EE897Q35044486-6FB9A434-197E-4534-B5F6-62BF15527244Q36142379-C80F5E75-44FB-4402-8BEF-189A80D8AB61Q36504064-7FDBDEAC-D538-42E0-89D2-02821D157F74Q37057272-E7A0BF30-F265-4382-9905-AE10FB6A9C86Q37604055-7B7EE87A-86F0-43C3-A465-B6CB234AC17EQ38547662-DA2B5FEB-E721-41E8-B262-55D38B83482CQ38739505-5F3DDAA9-3710-4194-AB3F-14CE7B1E6BCBQ39062945-240C678E-1D83-42BE-BE16-58300A7EDE8FQ41199012-3316FE62-CBF6-4FA7-97F8-8F902B828C61Q45021910-C4B97CDF-A783-40E9-99BD-DA15A64EC5A5Q46558453-A00B15C4-EEDC-4D39-B21C-1779F3947E37Q47689697-5E1B39B8-2160-4041-A025-7231EC9CD323Q48132232-0640D000-7A44-474A-8FD8-7B3BC309D42EQ48547546-5D7A1D98-E1DB-495C-B6F7-498CDB4127D2Q52613291-4422944B-6408-4957-8FD9-1DE6A95F6005Q52679169-5F1982B8-32B8-43DC-81FD-149CE54D875CQ55365163-BDE74E76-005D-43FE-A3F7-5B92FCEB9398
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Open questions for Alzheimer's disease immunotherapy.
@en
type
label
Open questions for Alzheimer's disease immunotherapy.
@en
prefLabel
Open questions for Alzheimer's disease immunotherapy.
@en
P2860
P356
P1476
Open questions for Alzheimer's disease immunotherapy.
@en
P2093
Todd E Golde
P2860
P2888
P356
10.1186/ALZRT233
P407
P577
2014-01-07T00:00:00Z
P5875
P6179
1019950382